The influence of deep brain stimulation on reward and attention in Parkinson*s disease

The influence of deep brain stimulation on reward and attention in Parkinson*s disease - Parkinson*s disease and reward

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40948

Enrollment

Registered

2014-08-26

Start date

2015-06-25

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

please see protocol

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients implanted with a DBS device for the treatment of Parkinson*s. - Written Informed Consent - Age > 18 years - clearly defined on-phase - Patients with bilateral electrode implants will only be included if the stimulation is generated by one external pulse generator (Kinetra, ActivaPC, or ActivaRC). - Absence of dementia or major psychiatric illness

Exclusion criteria

Exclusion criteria: - Color blindness - Patients who use dopamine agonists (e.g., ropinirole, pramiprexol will not be enrolledallowed, only L-dopa will be allowed. - Anticholinergic medication (e.g., trihexiphedidyl, benzhexol etc.) - History of psychiatric illnesses (e.g., psychosis, bipolar disorder) - Previous functional stereotactic neurosurgery

Design outcomes

Primary

Measure	Time frame
Primary study parameters are reaction time and accuracy (first block), and perseveration/response reversal of earlier choices (block 2).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)